Large-scale testing (Phase 3)Study completedNCT04702009
What this trial is testing
Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer
Who this might be right for
Advanced Lung CarcinomaNon-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 33